Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model

Virology Journal

Volumn 3, Issue , 2006, Pages

  Schleiss, Mark R ^a   Anderson, Jodi L ^a   McGregor, Alistair ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYCLIC CIDOFOVIR; GREEN FLUORESCENT PROTEIN; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; FETUS MORTALITY; FISHER EXACT TEST; MATERNAL MORTALITY; NONHUMAN; THIRD TRIMESTER PREGNANCY; VIRUS CULTURE; VIRUS TRANSMISSION;

ANIMALS; ANTIVIRAL AGENTS; CYTOSINE; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ORGANOPHOSPHONATES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; ROSEOLOVIRUS; ROSEOLOVIRUS INFECTIONS;

ANIMALIA; CAVIA; CAVIA PORCELLUS; CYTOMEGALOVIRUS;

EID: 33746665299     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-9     Document Type: Article

References (18)

1. Griffiths PD, Walter S: Cytomegalovirus. Curr Opinion Infect Dis 2005, 18:241-5.
2. Kimberlin DW, Lin CY, Sanchez PJ, et al.: Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003, 143:16-25.
3. Revello MG, Percivalle E, Baldanti F, et al.: Prenatal treatment of congenital human cytomegalovirus infection by fetal intravascular administration of ganciclovir. Clin Diagn Virol 1993, 1:61-7.
4. Matsuda H, Kawakami Y, Furuya K, et al.: Intrauterine therapy for a cytomegalovirus-infected symptomatic fetus. BJOG 2004, 111:756-7.
5. Puliyanda DP, Silverman NS, Lehman D, et al.: Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis 2005, 7:71-4.
6. Schleiss MR, Lacayo JC: The Guinea Pig Model of Congenital Cytomegalovirus Infection. In Cytomegaloviruses: Molecular Biology and Immunology, Chapter 25 Edited by: Reddehase MJ. Horizon Scientific Press; 2006:525-50.
7. Matthews T, Boehme R: Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988, 10(Suppl 3):S490-4.
8. Beadle JR, Hartline C, Aldern KA, et al.: Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro. Antimicrob Agents Chemother 2002, 46:2381-6.
9. Bourne N, Bravo FJ, Bernstein DI: Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals. Antiviral Res 2000, 47:103-9.
10. White DR, Choo DI, Stroup G, et al.: Effect of cidofovir on cytomegalovirus-induced hearing loss in a guinea pig model. Arch Otolaryngol Head Neck Surg 2006 in press.
11. McGregor A, Schleiss MR: Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli. Mol Genet Metab 2001, 72:15-26.
12. McGregor A, Liu F, Schleiss MR: Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83). J Virol 2004, 78:9872-89.
13. Schleiss MR, McVoy M: Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Rev Anti Infect Ther 2004, 2:389-403.
14. Schleiss MR: Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. ILAR J 2006, 47:65-72.
15. Fox DS, Schleiss MR: Sequence and transcriptional analysis of the guinea pig cytomegalovirus UL97 homolog. Virus Genes 1997, 15:255-64.
16. Nigro G, Adler SP, La Torre R, et al.: Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005, 353:1350-62.
17. Chang WL, Tarantal AF, Zhou SS, et al.: A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J Virol 2002, 76:9493-504.
18. McGregor A, Liu F, Schleiss MR: Identification of essential and non-essential genes of the guinea pig cytomegalovirus (GPCMV) genome via transposome mutagenesis of an infectious BAC clone. Virus Res 2004, 101:101-8.